Novartis will double down on China, investing over CNY3.3 billion (USD479 million) to expand R&D, manufacturing, and operations, the Swiss pharma giant said. It also unveiled a CNY1.8 billion second-phase project at its Shanghai plant, which marks its 10th anniversary this year.